Related Articles
Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells
CD147 promotes epithelial‑mesenchymal transition of prostate cancer cells via the Wnt/β‑catenin pathway
suPAR, a soluble form of urokinase plasminogen activator receptor, inhibits human prostate cancer cell growth and invasion
Juglone suppresses epithelial‑mesenchymal transition in prostate cancer cells via the protein kinase B/glycogen synthase kinase‑3β/Snail signaling pathway
Urokinase-type plasminogen activator induces proliferation in breast cancer cells